Chengdu Ambosens Technology Co., Ltd - chemistry life science chemical reagent analysis chromatography Materials Science

Product Catalog

Large Packaging Inquiry

SDS and COA

Advanced Search

Quality system

PRODUCT SERVICE

Structured Search

Large Packaging Inquiry

Product Center

About Us

Company Profile

Chengdu Ambosens Technology Co. , Ltd. is specialized in the in-depth development of natural amino acids, non-natural amino acids, amino acid derivatives, peptides and other products. The company integrates technical research and development, production and sales, technical services in one. Companies and Sichuan University, Sichuan Normal University and other institutions of higher learning in-depth cooperation to achieve production, learning, research in-depth integration. With many pharmaceutical companies, CRO (CDMO) companies long-term cooperation, to provide customer satisfaction products and services. The company has many years of industry experience and project management experience R & D technology team; Long-term technology incubation, production magnification of the production management team. And has a sound testing equipment, as well as quality control technical team, to provide quality products escort. Company in line with the“Realistic, innovative, integrity, win-win” concept, looking forward to make more friends, and you go hand in hand to create brilliant!

News

These bizarre ancient species are rewriting animal evolution

The revolutionary animal lived and died in the muck. In its final hours, it inched across the sea floor, leaving a track like a tyre print, and finally went still. Then geology set to work. Over the next half a billion years, sediment turned to stone, preserving the deathbed scene. The fossilized creature looks like a piece of frayed rope measuring just a few centimetres wide. But it was a trailblazer among living things.

May 7, 2024

Antimicrobial resistance

The threat to health care posed by the misuse of antimicrobial drugs has not crept up on us. As long ago as 1945, bacteriologist Alexander Fleming said, after winning a Nobel prize for his part in the discovery of penicillin, that overuse of the drug might lead to forms of bacteria that were resistant to its effects. If left unchecked, drug-resistant diseases could kill more people than cancer. Despite the warnings, and a global consensus among scientists and policymakers that something must be done to address resistance to antimicrobial drugs, society has struggled to respond.

May 7, 2024

Fresh evidence challenges the consensus view of active sites in an industrial catalyst

Metal ions trapped in crystalline microporous solids known as zeolites are promising solid-state catalysts for a wide variety of oxidation reactions1–3. In the past few decades, there has been intense research into the structure and nuclearity (the number of metal ions) of the active sites in these zeolite-based catalysts4,5. Despite these efforts, there is still no agreement on the nuclearity: the proposed number of metal ions in the active sites ranges from one to three1,2,4,5. Writing in Nature, Gordon et al.6 propose that there are two titanium ions in the active sites of a well-characterized industrial zeolite catalyst called titanium silicalite-1 (TS-1), challenging the widely accepted idea that there is only one. Their work has implications not only for TS-1, but also for other metal-containing zeolites for which the structure of the active sites is not yet fully established.

May 7, 2024

These bizarre ancient species are rewriting animal evolution

May 7, 2024